Gavin Baker’s Teladoc Health TDOC Stock Holding History

Gavin Baker’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-32,200	Closed	-$7.06M	–	50
2020 Q3	$7.06M	Buy	+32,200	New	+$6.82M	0.67%	32

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Gavin Baker's TDOC Position: Q4 2020 in Review

Gavin Baker sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 32,200 shares — an estimated $7.06M sold.

Gavin Baker first reported a position in TDOC in Q3 2020 and held it in 1 quarter. The position peaked at $7.06M in Q3 2020. 901 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

Gavin Baker reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
Gavin Baker sold 32,200 Teladoc Health shares in Q4 2020, an estimated $7.06M.
Gavin Baker first reported a position in Teladoc Health in Q3 2020 and held it in 1 quarter.
Gavin Baker's Teladoc Health position peaked at $7.06M in Q3 2020.
901 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on Atreides Management's 13F filing for Q4 2020, filed 16 Feb 2021.